BNOX
Price:
$0.2531
Market Cap:
$20.19M
Bionomics Limited is an Australian biopharmaceutical company operating at the clinical stage, dedicated to the discovery and advancement of innovative therapeutic compounds. Its research efforts primarily target central nervous system disorders and various cancers, with operations spanning Australia and the United States. A key experimental medicine in its portfolio is BNC210. This compound, which functions as a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, has successfully concluded Phase 2 trials for addressing social anxiety disorder and post-traumatic stress disorder. The company is also developing BNC375, a small molecule therapeutic aimed at improving cognit...[Read more]
Industry
Biotechnology
IPO Date
2021-12-16
Stock Exchange
NASDAQ
Ticker
BNOX
According to Bionomics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -99.31% compared to the average of -2.55 of the last 4 quarters.
The mean historical PE Ratio of Bionomics Limited over the last ten years is -944.14. The current -0.02 PE Ratio has changed -99.81% with respect to the historical average. Over the past ten years (40 quarters), BNOX's PE Ratio was at its highest in in the June 2020 quarter at 106.68K. The PE Ratio was at its lowest in in the September 2020 quarter at -7129445.28.
Average
-944.14
Median
-563.14
Minimum
-2356.03
Maximum
-1.43
Discovering the peaks and valleys of Bionomics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 205.62%
Maximum Annual PE Ratio = -1.43
Minimum Annual Increase = -95.37%
Minimum Annual PE Ratio = -2356.03
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | -1.43 | -95.37% |
| 2025 | -30.87 | -62.72% |
| 2024 | -82.80 | -49.84% |
| 2023 | -165.08 | -72.82% |
| 2022 | -607.46 | -74.22% |
| 2021 | -2356.03 | 1.22% |
| 2020 | -2327.56 | 46.79% |
| 2019 | -1585.65 | 205.62% |
| 2018 | -518.83 | -70.62% |
| 2017 | -1765.70 | 145.40% |
The current PE Ratio of Bionomics Limited (BNOX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-38.37
5-year avg
-177.53
10-year avg
-944.14
Bionomics Limited’s PE Ratio is greater than BiondVax Pharmaceuticals Ltd. (-20.48), greater than Aptose Biosciences Inc. (-0.65), greater than Tricida, Inc. (-0.03), greater than Gamida Cell Ltd. (-0.08), greater than Tectonic Therapeutic, Inc. (-5.80), less than Nabriva Therapeutics plc (-0.00), less than LumiraDx Limited (-0.01), greater than Gritstone bio, Inc. (-0.03), greater than NanoString Technologies, Inc. (-0.03), greater than TNF Pharmaceuticals, Inc. (-0.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -20.48 | $4.97M | |
| -0.65 | $4.36M | |
| -0.03 | $5.95M | |
| -0.08 | $4.34M | |
| -5.80 | $500.03M | |
| -0.00 | $323.00 | |
| -0.01 | $5.10M | |
| -0.03 | $3.80M | |
| -0.03 | $5.07M | |
| -0.21 | $9.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionomics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionomics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bionomics Limited's PE Ratio?
How is the PE Ratio calculated for Bionomics Limited (BNOX)?
What is the highest PE Ratio for Bionomics Limited (BNOX)?
What is the 3-year average PE Ratio for Bionomics Limited (BNOX)?
What is the 5-year average PE Ratio for Bionomics Limited (BNOX)?
How does the current PE Ratio for Bionomics Limited (BNOX) compare to its historical average?